Strumento inattivo

Altre lingue DARA Biosciences Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

DARA BioSciences : Granted Waiver of Product and Establishment Fees by the FDA	08/01/15
DARA BioSciences : Announces Participation at the Aegis Capital Corporation Healthcare and Technology Conference in Las Vegas	16/09/14
DARA BioSciences : Announces New Retail Patient Savings Program to Support Market Demand for DARA's Flagship Oncology Products	11/05/14
DARA BioSciences : Announces Addition of Soltamox(R), (Tamoxifen Citrate) Oral Solution, to the Authorized Federal Supply Schedule Price List	11/05/14

Non ci sono risultati per questa ricerca